One in five women suffering from breast cancer has a particularly aggressive, rapidly growing HER2-positive type of tumor. And usually, surgery, chemotherapy and/or targeted year-long therapy are the available treatments. But now a study conducted by experts from India's Tata Memorial cancer research institute indicates that a shorter, targeted therapy ranging between three and six […]
The post Study: Much Shorter Course of Drug Therapy Is Effective for Some with Early-Stage Breast Cancer appeared first on L.A. Focus Newspaper.
